Xenetic Biosciences XBIO
NASDAQ XBIO
$2.24 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Cost of Revenue (2011 - 2017)

Updated

Xenetic Biosciences (XBIO) posted Cost of Revenue of $97,028 for Q3 2017, up 64.2% from the prior quarter.

Analysis

Xenetic Biosciences (XBIO) Cost of Revenue (2011 - 2017) Analysis & Trends

For FY2013, Xenetic Biosciences' Cost of Revenue came in at $8,435.

  • In prior years, Xenetic Biosciences' Cost of Revenue was $44,838 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Xenetic Biosciences 5.25 Mn -20.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 97,028.00
Jun 30, 2017 59,091.00
May 31, 2013 9,930.00
Feb 28, 2013 3,502.00
Nov 30, 2012 11,936.00
May 31, 2012 9,909.00
Feb 29, 2012 8,621.00
Nov 30, 2011 1,416.00
API Access

Xenetic Biosciences Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=XBIO&period=max&api_key=YOUR_API_KEY